Carcinoma in situ of unspecified part of intestine is a localized cancerous condition where abnormal cells are present in the intestinal lining without invasion into surrounding tissues. This condition is clinically significant as it may progress to invasive cancer if left untreated. Accurate coding with ICD-10 Code D01.40 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and monitoring.
ICD-10 Code D01.40 represents carcinoma in situ of an unspecified part of the intestine, indicating the presence of malignant cells confined to the intestinal mucosa. This code is used when the specific site of the carcinoma is not documented. It is crucial for clinical documentation and billing to ensure accurate representation of the patient's condition and to facilitate appropriate treatment and follow-up.
Carcinoma in situ of unspecified part of intestine is characterized by the presence of malignant epithelial cells that have not invaded surrounding tissues. This condition may arise from various risk factors, including genetic predisposition, environmental exposures, and chronic inflammatory conditions. Early detection and intervention are critical to prevent progression to invasive cancer.
ICD-10 Code D01.40 is utilized in SOAP notes to document the diagnosis of carcinoma in situ of an unspecified part of the intestine. It plays a vital role in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code D01.40 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of carcinoma in situ. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of carcinoma in situ of unspecified part of intestine requires prompt medical intervention to prevent progression to invasive cancer. Treatment options may vary based on the specific clinical scenario.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D01.40 is critical in medical billing, particularly in hospital, emergency room, or oncology settings, to ensure accurate claims processing.
| CPT Code | Description |
|---|---|
| 45378 | Colonoscopy, flexible, diagnostic, including collection of specimen(s) by brushing or washing. |
| 44140 | Colectomy, partial, with anastomosis. |
| 88305 | Pathology examination, surgical, for biopsy specimens. |
| 99214 | Established patient office visit, level 4. |
Common Questions About Using ICD-10 Code D01.40 for Carcinoma in situ of unspecified part of intestine
What are the symptoms of carcinoma in situ of the intestine?
Symptoms may include abdominal pain, changes in bowel habits, unexplained weight loss, and gastrointestinal bleeding. However, many patients may be asymptomatic, making regular screening important.
How is carcinoma in situ diagnosed?
Diagnosis typically involves imaging studies, endoscopy, and biopsy to confirm the presence of abnormal cells in the intestinal lining. Pathological examination is essential for accurate diagnosis.
What is the treatment for carcinoma in situ?
Treatment often involves surgical resection of the affected area. Regular monitoring and follow-up are crucial to prevent progression to invasive cancer.
Is carcinoma in situ of the intestine considered cancer?
Yes, carcinoma in situ is classified as a form of cancer, as it involves the presence of malignant cells. However, it is non-invasive and has not spread beyond the mucosal layer.
Clinical Notes
SOAP notes
DAP notes
AI medical notes